Ironwood Pharmaceuticals | IRWD - Trade Creditors


Ironwood Pharmaceuticals reported $3.24M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Akebia Therapeutics USD 8.39M 12.8M Mar/2026
Almirall EUR 258.05M 58.66M Dec/2025
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Amarin USD 48.15M 2.8M Mar/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Astellas Pharma JPY 199.75B 17.8B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Charles River Laboratories USD 133.95M 14.85M Mar/2026
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Emergent BioSolutions USD 112.2M 500K Dec/2023
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Moderna USD 161M 156M Mar/2026
Myriad Genetics USD 32.6M 2.6M Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
PTC Therapeutics USD 25.48M 20M Mar/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
Takeda JPY 491.34B 23.75B Mar/2026
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024